Study of prevention of hair loss induced by chemotherpy for Japanese breast cancer patients with scalp cooling

Study of prevention of hair loss induced by chemotherpy for Japanese breast cancer patients with scalp cooling - Hair loss prevention with scalp cooling

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017657

Enrollment

150

Registered

2015-06-01

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Scalp Cooling

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with breast cancer Applicants of chemotherapy

Exclusion criteria

Exclusion criteria: Patients with Raynaud's disease or phenomenon Patients with high degree alopecia who need a wig Patients with cold agglutinin disease Patients with cryoglobulinemia Patients with cryofibrinogenemia

Design outcomes

Primary

Measure	Time frame
Rate of grade 3 or 4 of hair loss, according to WHO classification, or use of a wig or a hat	—

Secondary

Measure	Time frame
Degrees of hair loss assessed by patients Patients' satisfaction Patients' thoughts Adverse events	—

Countries

Japan

Contacts

Public ContactShozo Ohsumi

NHO Shikoku Cancer Center Breast Oncology

sosumi@shikoku-cc.go.jp089-999-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026